Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries
- PMID: 35455667
- PMCID: PMC9032232
- DOI: 10.3390/jpm12040552
Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries
Abstract
The Global Globin Network (GGN) is a project-wide initiative of the Human Variome/Global Variome Project (HVP) focusing on haemoglobinopathies to build the capacity for genomic diagnosis, clinical services, and research in low- and middle-income countries. At present, there is no framework to evaluate the improvement of care, treatment, and prevention of thalassaemia and other haemoglobinopathies globally, despite thalassaemia being one of the most common monogenic diseases worldwide. Here, we propose a universally applicable system for evaluating and grouping countries based on qualitative indicators according to the quality of care, treatment, and prevention of haemoglobinopathies. We also apply this system to GGN countries as proof of principle. To this end, qualitative indicators were extracted from the IthaMaps database of the ITHANET portal, which allowed four groups of countries (A, B, C, and D) to be defined based on major qualitative indicators, supported by minor qualitative indicators for countries with limited resource settings and by the overall haemoglobinopathy carrier frequency for the target countries of immigration. The proposed rubrics and accumulative scores will help analyse the performance and improvement of care, treatment, and prevention of haemoglobinopathies in the GGN and beyond. Our proposed criteria complement future data collection from GGN countries to help monitor the quality of services for haemoglobinopathies, provide ongoing estimates for services and epidemiology in GGN countries, and note the contribution of the GGN to a local and global reduction of disease burden.
Keywords: Global Globin Network; Hemoglobinopathy VCEP; Human Variome Project; disease burden; epidemiology; haemoglobinopathy; low- and middle-income countries; prevention program; thalassaemia.
Conflict of interest statement
John Burn is the Vice-Chair of QuantuMDx Ltd. The other authors declare no conflict of interest.
Figures
Similar articles
-
Global Globin Network and adopting genomic variant database requirements for thalassemia.Database (Oxford). 2024 Sep 4;2024:baae080. doi: 10.1093/database/baae080. Database (Oxford). 2024. PMID: 39231257 Free PMC article.
-
Increasing the involvement of diverse populations in genomics-based health care-lessons from haemoglobinopathies.J Community Genet. 2017 Oct;8(4):311-318. doi: 10.1007/s12687-017-0327-3. Epub 2017 Sep 6. J Community Genet. 2017. PMID: 28879424 Free PMC article.
-
Prevention and control of haemoglobinopathies.Bull World Health Organ. 1995;73(3):375-86. Bull World Health Organ. 1995. PMID: 7614670 Free PMC article. Review.
-
Screening of (-SEA) α-thalassaemia using an immunochromatographic strip assay for the ζ-globin chain in a population with a high prevalence and heterogeneity of haemoglobinopathies.J Clin Pathol. 2017 Jan;70(1):63-68. doi: 10.1136/jclinpath-2016-203765. Epub 2016 Jun 16. J Clin Pathol. 2017. PMID: 27312111
-
The challenge of haemoglobinopathies in resource-poor countries.Br J Haematol. 2011 Sep;154(6):736-44. doi: 10.1111/j.1365-2141.2011.08742.x. Epub 2011 Jul 5. Br J Haematol. 2011. PMID: 21726207 Review.
Cited by
-
Addressing Thalassaemia Management from Patients' Perspectives: An International Collaborative Assessment.Medicina (Kaunas). 2024 Apr 18;60(4):650. doi: 10.3390/medicina60040650. Medicina (Kaunas). 2024. PMID: 38674296 Free PMC article.
-
Editorial: Insights in thalassemia: from genomics to clinical practice.Front Pediatr. 2023 Jul 14;11:1222946. doi: 10.3389/fped.2023.1222946. eCollection 2023. Front Pediatr. 2023. PMID: 37520048 Free PMC article. No abstract available.
-
Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.Int J Mol Sci. 2024 Apr 12;25(8):4263. doi: 10.3390/ijms25084263. Int J Mol Sci. 2024. PMID: 38673849 Free PMC article. Review.
-
Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by HBBAS3 Gene Addition and Mutation-Specific RNA Interference.Cells. 2023 Dec 15;12(24):2848. doi: 10.3390/cells12242848. Cells. 2023. PMID: 38132168 Free PMC article.
-
Special Issue "Personalized Medicine in Blood Disease of Children".J Pers Med. 2024 Mar 5;14(3):285. doi: 10.3390/jpm14030285. J Pers Med. 2024. PMID: 38541027 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources